過敏性氣喘治療市場：依藥物類型、給藥途徑及地區分類。

Allergic Asthma Therapeutics Market, By Drug Type, By Route of Administration, and By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，過敏性氣喘治療市場規模將達到 79.5 億美元，到 2033 年將達到 99.1 億美元。預計 2026 年至 2033 年的複合年成長率為 3.2%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	79.5億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	3.20%	2033年市場規模預測：	99.1億美元

過敏性氣喘（也稱為過敏性氣喘）是一種慢性發炎性疾病。這是一種呼吸系統疾病，患者吸入過敏原後氣道會收縮。氣喘氣喘吸入過敏原後呼吸困難的症狀。這是因為氣道在過敏反應中腫脹所致。常見的過敏原包括花粉、寵物皮屑和黴菌孢子。這種類型的氣喘在兒童和成人中都很常見。過敏性氣喘的症狀包括呼吸急促、咳嗽、喘息、鼻塞、眼睛發癢和皮疹。氣喘是一種長期發炎性肺部疾病，其特徵是氣道發炎和狹窄，由環境和遺傳因素觸發。空氣污染、氣霧劑清潔劑、香菸煙霧、燃燒的木材和強烈氣味等刺激物不一定會引發過敏反應，但它們會刺激氣道並加重氣喘症狀。氣喘發作的特徵是支氣管收縮，即氣道周圍肌肉收縮，導致氣道變窄，呼吸困難。預計在預測期內，呼吸系統疾病發病率的上升以及主要公司的策略性業務擴張將推動全球過敏性氣喘治療市場的成長。

市場動態

預計在預測期內，呼吸系統疾病發病率的上升以及對經濟有效療法的需求不斷成長，將推動全球過敏性氣喘治療市場的成長。此外，日益嚴重的空氣污染和慢性阻塞性肺病（COPD）病例的激增也是促進市場成長的因素。例如，根據世界衛生組織（WHO）2023年3月16日的數據，慢性阻塞性肺病是全球第三大死因，2020年造成323萬人死亡。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及領先企業採取的競爭策略。
本研究根據以下參數介紹了全球過敏性氣喘治療市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球過敏和氣喘治療市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球過敏性氣喘治療市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

ASLAN Pharmaceuticals
Takeda Pharmaceutical Company Limited
CHIESI Farmaceutici SpA
CSL
NIOX
Fountain Therapeutics
Eli Lilly and Company
GSK plc.
Infinity Pharmaceuticals, Inc.
Mabtech
Kineta Inc.
Marinomed Biotech AG
Mycenax Biotech Inc.
AstraZeneca
Panacea Biotec

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI4019

Allergic Asthma Therapeutics Market is estimated to be valued at USD 7.95 Bn in 2026 and is expected to reach USD 9.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.95 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.20%	2033 Value Projection:	USD 9.91 Bn

Allergic asthma, also known as allergy-induced asthma, is a chronic inflammatory condition Allergic asthma is a breathing condition where the airways you breathe through tighten when someone inhale an allergen. Allergic asthma is when someone develop breathing difficulties from inhaling allergens. It occurs when the airways swell as part of an allergic reaction. Common allergens include pollen, dander and mold spores. This type of asthma is very common in both children and adults. Symptoms of allergic asthma can include shortness of breath, coughing, wheezing, stuffy nose, itchy eyes and a rash. Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Irritants such as air pollution, aerosol cleaning products, tobacco smoke, wood fires, and strong odors don't cause an allergic reaction. But they may inflame your airways and make asthma symptoms worse. An asthma attack is characterized by tightening of the muscles around the airways (bronchoconstriction), which narrows the airway and makes breathing difficult. The rising incidence of respiratory diseases and the strategic expansions by the key players are expected to propel the growth of global allergic asthma therapeutics market over the forecast period.

Market Dynamics

The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the global allergic asthma therapeutics market growth over the forecast period. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. For instance, on March 16, 2023, according to the World Health Organization (WHO), Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2020.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global allergic asthma therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are ASLAN Pharmaceuticals, Takeda Pharmaceutical Company Limited, CHIESI Farmaceutici S.p.A., CSL, NIOX, Fountain Therapeutics, Eli Lilly and Company, GSK plc., Infinity Pharmaceuticals, Inc., Mabtech, Kineta Inc., Marinomed Biotech AG, Mycenax Biotech Inc., AstraZeneca, and Panacea Biotec.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global allergic asthma therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic asthma therapeutics market

Detailed Segmentation:

Global Allergic Asthma Therapeutics Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
Corticosteroids
Bronchodilators
Leukotriene modifiers
Immunotherapy
Biologics
Others
Global Allergic Asthma Therapeutics Market By Route of Administration:
Oral
Inhaled
Others
Global Allergic Asthma Therapeutics Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
ASLAN Pharmaceuticals *
Takeda Pharmaceutical Company Limited
CHIESI Farmaceutici S.p.A.
CSL
NIOX
Fountain Therapeutics
Eli Lilly and Company
GSK plc.
Infinity Pharmaceuticals, Inc.
Mabtech
Kineta Inc.
Marinomed Biotech AG
Mycenax Biotech, Inc.
AstraZeneca
Panacea Biotec

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Future Prospective
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- PORTER's Analysis

4. Global Allergic Asthma Therapeutics Market, By Drug Type, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Leukotriene modifiers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Allergic Asthma Therapeutics Market, By Route of Administration, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segments Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Inhaled
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Allergic Asthma Therapeutics Market, By Region, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

ASLAN Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CHIESI Farmaceutici S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CSL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NIOX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Fountain Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Infinity Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mabtech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Kineta Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Marinomed Biotech AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mycenax Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Panacea Biotec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies